人体中35S标记抗甲状腺药物的代谢
Metabolism of 35S-labelled antithyroid drugs in man.
作者信息
Alexander W D, Evans V, MacAulay A, Gallagher T F, Londono J
出版信息
Br Med J. 1969 May 3;2(5652):290-1. doi: 10.1136/bmj.2.5652.290.
Abstract
Differences in the metabolic fate of antithyroid drugs influence the optimal frequency of administration and their therapeutic efficacy. (35)S propylthiouracil differed from the (35)S imidazoles (carbimazole and methimazole) in the more rapid absorption and excretion and the shorter biological half-life in the plasma of the former. Renal function may have a more important influence on the biological half-life of the drugs than thyroid status. Further work is required to determine the optimal frequency of administration for each compound.
摘要
抗甲状腺药物代谢命运的差异会影响给药的最佳频率及其治疗效果。放射性硫标记的丙硫氧嘧啶与放射性硫标记的咪唑类药物（卡比马唑和甲巯咪唑）不同，前者吸收和排泄更快，血浆中的生物半衰期更短。肾功能对药物生物半衰期的影响可能比甲状腺状态更为重要。需要进一步开展研究以确定每种化合物的最佳给药频率。
相似文献
1
Metabolism of 35S-labelled antithyroid drugs in man.人体中35S标记抗甲状腺药物的代谢
Br Med J. 1969 May 3;2(5652):290-1. doi: 10.1136/bmj.2.5652.290.
2
Biliary excretion of 35 S-labelled propylthiouracil, methimazole and carbimazole in untreated and pentobarbitone pretreated rats.
Biochem Pharmacol. 1972 Feb 1;21(3):363-77. doi: 10.1016/0006-2952(72)90348-6.
3
The acclumulation of 35 S-antithyroid drugs by the thyroid gland.
J Clin Endocrinol Metab. 1972 May;34(5):847-51. doi: 10.1210/jcem-34-5-847.
4
The metabolism of 35S-labelled antithyroid drugs in thyrotoxic, adenomatous, neoplastic and normal human thyroid.
Clin Sci. 1973 Jun;44(6):24P. doi: 10.1042/cs044024p.
5
6
35-S-antithyroid drug concentration and organic binding of iodine in the human thyroid.人体甲状腺中35-S-抗甲状腺药物浓度及碘的有机结合
Clin Endocrinol (Oxf). 1975 Nov;4(6):609-15. doi: 10.1111/j.1365-2265.1975.tb01930.x.
7
[Excretion of antithyroid drugs in maternal milk].
Ugeskr Laeger. 1982 May 31;144(22):1635-7.
8
Pharmacokinetics of antithyroid drugs.
Klin Wochenschr. 1982 Jun 1;60(11):531-9. doi: 10.1007/BF01724208.
9
The placental transfer of propylthiouracil, methimazole and carbimazole.丙硫氧嘧啶、甲巯咪唑和卡比马唑的胎盘转运。
J Clin Endocrinol Metab. 1977 Dec;45(6):1187-93. doi: 10.1210/jcem-45-6-1187.
10
Clinical pharmacokinetics of antithyroid drugs.抗甲状腺药物的临床药代动力学
Clin Pharmacokinet. 1981 Nov-Dec;6(6):401-28. doi: 10.2165/00003088-198106060-00001.
引用本文的文献
1
Evaluation of potential thiamazole exposure of owners of orally treated hyperthyroid cats.评估接受口服药物治疗的甲状腺机能亢进猫的主人潜在的甲巯咪唑暴露情况。
J Feline Med Surg. 2022 Jun;24(6):e138-e141. doi: 10.1177/1098612X221091738. Epub 2022 Apr 26.
2
Methimazole as a protectant against cisplatin-induced nephrotoxicity using the dog as a model.
Cancer Chemother Pharmacol. 1993;33(1):25-30. doi: 10.1007/BF00686018.
3
The pharmacokinetics of methimazole after oral administration of carbimazole and methimazole, in hyperthyroid patients.甲亢患者口服卡比马唑和甲巯咪唑后甲巯咪唑的药代动力学。
Br J Clin Pharmacol. 1980 Feb;9(2):137-43. doi: 10.1111/j.1365-2125.1980.tb05823.x.
4
Potential radiopharmaceuticals for the detection of ocular melanoma. Part I. 5-iodo-2-thiouracil derivatives.用于检测眼部黑色素瘤的潜在放射性药物。第一部分。5-碘-2-硫脲衍生物。
Eur J Nucl Med. 1983;8(2):45-51. doi: 10.1007/BF00252555.
5
Pharmacokinetics of antithyroid drugs.
Klin Wochenschr. 1982 Jun 1;60(11):531-9. doi: 10.1007/BF01724208.
6
Clinical pharmacokinetics of antithyroid drugs.抗甲状腺药物的临床药代动力学
Clin Pharmacokinet. 1981 Nov-Dec;6(6):401-28. doi: 10.2165/00003088-198106060-00001.
7
Influence of thyroid dysfunction on drug pharmacokinetics.甲状腺功能障碍对药物药代动力学的影响。
Clin Pharmacokinet. 1981 Jul-Aug;6(4):275-97. doi: 10.2165/00003088-198106040-00003.
8
Thyroid disorders--management.甲状腺疾病——管理
Br Med J. 1970 Mar 21;1(5698):745-8. doi: 10.1136/bmj.1.5698.745.
9
Pharmacokinetic properties and bioavailability of methimazole.甲巯咪唑的药代动力学特性及生物利用度。
Clin Pharmacokinet. 1985 Sep-Oct;10(5):443-50. doi: 10.2165/00003088-198510050-00006.
10
Initial treatment of thyrotoxic Graves' disease with methimazole: a randomized trial comparing different dosages.
J Endocrinol Invest. 1987 Jun;10(3):291-5. doi: 10.1007/BF03348132.
本文引用的文献
1
Studies on the metabolism of thiourea. II. The metabolic fate of thiourea in the thyroid gland.硫脲代谢的研究。II. 硫脲在甲状腺中的代谢归宿。
J Biol Chem. 1950 Oct;186(2):717-23.
2
The desulfuration of thiourea by thyroid cytoplasmic particulate fractions.甲状腺细胞质微粒组分对硫脲的脱硫作用。
J Biol Chem. 1959 Apr;234(4):949-54.
3
Development of thyroidal suppression by triiodothyronine during six months' treatment of thyrotoxicosis with antithyroid drugs.在用抗甲状腺药物治疗甲状腺毒症六个月期间，三碘甲状腺原氨酸引起的甲状腺抑制的发展情况。
J Clin Endocrinol Metab. 1967 Dec;27(12):1682-9. doi: 10.1210/jcem-27-12-1682.
Zotero 插件